BROOKS logo

Brooks Labs

(NSE: BROOKS)

BROOKS

110

0.00 (0.00%)

Brooks Labs Price Chart

Note: The data used to display charts is delayed by 15 mins as per guidelines.

Brooks Labs Price Chart

Note: The data used to display charts is delayed by 15 mins as per guidelines.

Brooks Labs Price Summary

Today High

111.9

Today Low

107.2

52 Week High

113.85

52 Week Low

107.2

Brooks Labs Fundamentals

Market Cap

219.9 Cr

CASA

0.0

No. Of Shares

2.5 Cr

P/E

0.0

P/B

2.4

Face Value

10.0

Dividend Yeild

0.0

Book Value

26.0

Net Interest Income

16.9

Cost to Income

NA

Promoter Holdings

66.4

EPS

-6.3

CAR

NA

ROE

-19.2

ROCE

-5.4

Profit Growth

NA

Brooks Labs Peer Comparison

COMPANY

PRICE

MCAP (cr)

P/B

P/E

EPS

ROE

ROCE

NII

Brooks Labs

110

219.9 Cr

2.4

0.0

-6.3

-19.2

-5.4

16.9

Mangalam Drugs

144.05

225.2 Cr

1.2

5.6

17.7

23.8

28.0

62.3

SMS Lifesciences

655.5

203.5 Cr

1.2

11.4

43.6

11.0

14.4

22.0

Bafna Pharma

103.8

241.5 Cr

5.7

55.7

2.5

22.3

10.6

4.0

Krebs Biochem

113.55

245.9 Cr

-3.7

-6.1

-14.5

0.0

-40.3

7.2

Wanbury

65.65

256.4 Cr

-1.6

0.0

-5.0

0.0

46.9

40.2

FAQ’s on Brooks Labs

About Brooks Labs

The Company was originally incorporated as Brooks Laboratories Limited on January 23, 2002. Company was initially promoted for manufacturing of latest molecules in Injectables, tablets and dry syrups for the domestic customers. The Company set up a facility for manufacturing Tablets, Dry Syrup and Injectables, which was supported by a research and development centre at Baddi, Himachal Pradesh. The Company started its commercial production in the month of June 2006 and became profitable from the very first year of its production.

The company has set up a well equipped manufacturing unit at Baddi, Himachal Pradesh in the year 2006 and has been awarded a G.M.P Certification for following Good Manufacturing Practices under “Revised Schedule M” of Drugs & Cosmetics Rules, 1945 in respect of various categories of Tablets, Capsules, Liquid Orals, Dry Syrups, SVP (Liquid & Dry) and Ophthalmic Section by The Health & Family Welfare Department, Himachal.

Company’s manufacturing facility at Baddi is capable of manufacturing products confirming to TRS 908 of 2003 (WHO GMP) standards. Its Quality Management System at the factory at Baddi is certified as complying to ISO 9001:2008.

Product of the company

The company has wide range of products catering to critical care segment in Parental Section like Beta Lactam, Cephalosporin & General dry powder Injectables, Ampoules and Liquid vials. These products are manufactured in accordance with highest international standards in facilities as per norms of WHO-GMP & ISO 9000-2008.

Some of the product categories are:

  • Beta Lactum
  • Cephalosporins
  • Carbapenems
  • General Injectable (Dry Powder)
  • General Injectable (Liquid)
  • Cortico Steroids

Trade Brooks Labs today

Create a free portfolio in Trinkerr and earn and grow along with peers